Between the recent news letter and now, one begins to wonder. I'm not a ZACK man, but one must also wonder why ZACK gave NBS all the accolades.
MC going below 90 seriously questions what management is thinking. We all know the company and it's platform, but now we must question the bottom line for all investors, including myself.
You/me-same page. Patience has always been my firtue. The entire BIO area remains in an infsnt stage. That being said/agreed, one must wait for solid definitive results before we see a spike due to financial or un-met medical results in the positive. I'm in no hurry tosell what remains on my books/portfolio. Your "existential"comment can be summed up as WHEN to buy. We all have a responsibility to do our own DD based on time/financial ability to HOLD.
That is why I bailed out 3 accounts w/NBS stk @ $3.63. Holding one acc to buy on the way down. Still made a "few $" , but nothing to write to ma about. Good entry point may be around the corner shortly.